BRADFORD PATRICIA A

SEC Form 4 insider trading activity

BRADFORD PATRICIA A has filed 4 SEC Form 4 filings (4 transaction rows) across 1 company, with disclosures dating back to 2025. 3 of those filings fall inside the rolling window. Most recent filing: Sep 25, 2026.

On the most recent filing, BRADFORD PATRICIA A is listed as Director at Phio Pharmaceuticals Corp. Inside the rolling window, BRADFORD PATRICIA A reported 2 open-market purchases totaling $19K in PHIO and no open-market sales. The largest disclosed transaction in the window is a purchase of 12,000 PHIO shares on Sep 15, 2026, worth $12K.

Companies traded

Other insiders at PHIO

Insider Buying

$19K

reported purchases (SEC code P)

Insider Selling

$0

reported sales (SEC code S)

Companies

1

in the rolling window

Source
PHIOPurchase$7KSep 25SEC ↗
PHIOPurchase$12KSep 16SEC ↗
Showing 1–2 of 2
1 / 1

Frequently asked questions

How many SEC Form 4 filings has BRADFORD PATRICIA A made?

BRADFORD PATRICIA A has filed 4 SEC Form 4 filings (4 transaction rows) across 1 company since 2025.

Which companies does BRADFORD PATRICIA A trade?

BRADFORD PATRICIA A has filed SEC Form 4 disclosures for 1 company, including PHIO.

When was BRADFORD PATRICIA A's most recent SEC Form 4 filing?

BRADFORD PATRICIA A's most recent SEC Form 4 filing on Tracefour is dated Sep 25, 2026.

What is BRADFORD PATRICIA A's total buy and sell value in the current window?

Inside the rolling retention window, BRADFORD PATRICIA A bought $19K and sold $0 based on SEC Form 4 filings.

What was BRADFORD PATRICIA A's largest disclosed transaction?

The largest disclosed transaction in the current window is a purchase of 12,000 PHIO shares on 2026-09-15, worth $12K, per SEC Form 4 filings.